Link Immunotherapeutics is developing immunotherapies with greater selectivity for tumors over normal tissue. To enable better patient responses to cancer therapies, Link is using an approach that balances affinity and avidity to generate novel immunotherapies. This approach involves selecting validated cancer targets and novel target combinations to build on existing knowledge to create better molecules. Ultimately, Link is building a team of strong individuals with unique skills and expertise to develop best-in-class and first-in-class antibody therapies.

Link Immunotherapeutics

Founded: 2020
Location: Seattle, WA
Employee range: 1 - 10
Funding: 10-100M

Short description:

Drug notes:

Long description:

Jobs: